Smoking and preterm birth: A novel effect of 17 alpha-hydroxyprogesterone caproate (17OHP-C)

被引:2
|
作者
Heyborne, Kent [1 ,2 ]
Allshouse, Amanda A. [2 ]
机构
[1] Denver Hlth, Denver, CO USA
[2] Univ Colorado, Aurora, CO USA
关键词
D O I
10.1016/j.ajog.2015.10.442
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
引用
收藏
页码:S220 / S221
页数:2
相关论文
共 50 条
  • [21] The effect of partial compliance on the prevention of recurrent preterm birth in women receiving weekly 17 alpha-hydroxyprogesterone caproate injections
    Haidar, Ziad A.
    Moussa, Hind N.
    Sibai, Baha M.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2016, 214 (01) : S288 - S288
  • [22] Conformity with treatment standards and pregnancy outcomes in patients receiving 17 alpha-hydroxyprogesterone caproate (17p) for preterm birth prophylaxis
    Istwan, Niki
    Rhea, Debbie
    Desch, Cheryl
    Stanziano, Gary
    Gonzalez-Quintero, Victor Hugo
    Tudela, Felipe Jose
    Romary, Leticia Maria
    Cordova, Yvette C.
    Achille, Fabienne
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2011, 204 : S81 - S81
  • [23] Does 17 alpha-hydroxyprogesterone caproate decrease the rate of preterm birth in women with an ultrasound-indicated cerclage?
    Rafael, Timothy
    Mackeen, Dhanya
    Berghella, Vincenzo
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2009, 201 (06) : S176 - S176
  • [24] 17 alpha-hydroxyprogesterone caproate - Perinatal mortality and pregnancy outcomes
    Gonzalez-Quintero, Victor Hugo
    Smarkusky, Loren
    Istwan, Niki
    Rhea, Debbie
    OBSTETRICS AND GYNECOLOGY, 2007, 109 (04): : 1S - 2S
  • [25] A trial of 17 alpha-hydroxyprogesterone caproate to prevent prematurity in twins
    Rouse, Dwight J.
    Caritis, Steve N.
    Peaceman, Alan M.
    Sciscione, Anthony
    Thom, Elizabeth A.
    Spong, Catherine Y.
    Varner, Michael
    Malone, Fergal
    Iams, Jay D.
    Mercer, Brian M.
    Thorp, John
    Sorokin, Yoram
    Carpenter, Marshall
    Lo, Julie
    Ramin, Susan
    Harper, Margaret
    Anderson, Garland
    Andrews, W. W.
    Northen, A.
    Sheppard, J.
    Tillinghast, J.
    Allard, D.
    Milluzzi, C.
    Heggie, C.
    Ehrenberg, H.
    Stetzer, B.
    Merlino, A.
    Berkowitz, R.
    Bousleiman, S.
    South, S.
    Paley, L.
    Carmona, V.
    Wapner, R.
    Hoffman, M.
    Talucci, M.
    Wilson, S.
    Tocci, C.
    Lake, M.
    Boggess, K.
    Dorman, K.
    Timlin, S.
    Grobman, W.
    Mallett, G.
    Dinsmoor, M.
    Simon, P.
    Huntley, M.
    Ramos, M.
    Johnson, F.
    Landon, M.
    Latimer, C.
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (05): : 454 - 461
  • [26] Medical cost savings associated with 17 alpha-hydroxyprogesterone caproate
    Bailit, Jennifer L.
    Votruba, Mark E.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2007, 196 (03) : 219 - 220
  • [27] Rates of recurrent preterm delivery in women receiving 17 alpha-hydroxyprogesterone caproate by gestational age and reason for prior preterm birth
    Istwan, Niki
    Rhea, Debbie
    Desch, Cheryl
    Stanziano, Gary
    Gonzalez-Quintero, Victor Hugo
    Cordova, Yvette C.
    Tudela, Felipe
    Marimon, Adrian
    Romary, Leticia Maria
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2011, 204 : S80 - S81
  • [28] 17 α-Hydroxyprogesterone Caproate (Makena™)In the Prevention of Preterm Birth
    Emma D. Deeks
    Pediatric Drugs, 2011, 13 : 337 - 345
  • [29] 17 α-Hydroxyprogesterone Caproate (Makena™) In the Prevention of Preterm Birth
    Deeks, Emma D.
    PEDIATRIC DRUGS, 2011, 13 (05) : 337 - 345
  • [30] Pharmacogenomics of 17-alpha hydroxyprogesterone caproate for recurrent preterm birth prevention
    Manuck, Tracy A.
    Watkins, W. Scott
    Moore, Barry
    Esplin, M. Sean
    Varner, Michael W.
    Jackson, G. Marc
    Yandell, Mark
    Jorde, Lynn
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2014, 210 (04) : 321.e1 - 321.e21